The addition of a personalized vaccine to standard adjuvant therapy reduced risk for recurrence or death by 42% among ...

The FDA has expanded its approval of Skyrizi to include subcutaneous induction for adults with moderately to severely active ...

The FDA has approved once-weekly insulin icodec-abae 700 U/mL for children aged 10 years and older with type 2 diabetes, Novo ...

Jordy Cohen’s interest in hypertension began when she was “working” in her father’s medical office at a tender age. “He was ...

Ophthalmic companies report updates on recent regulatory moves, studies and trials.The FDA approved Lytenava ...

Patients with ileal Crohn’s disease had significantly better clinical and endoscopic outcomes at week 54 with subcutaneous vs ...

For women in midlife, undergoing hormone therapy and taking GLP-1 receptor agonists at the same time was linked to ...

Grief. It can come in waves, or it can come all at once. There is no right way to grieve, and there is no single right way to ...

New guidance from ACOG addresses the use of GLP-1 receptor agonists around pregnancy and lactation, when safety data remain ...

A 25-year-old Black man presented to the Tufts Medical Center emergency department with blurred vision in both eyes.The ...

Preliminary results of a clinical trial indicate that starting patients on two IV antibiotics significantly reduces the ...

Cataract surgery in highly myopic eyes presents distinct challenges that require careful planning, surgical technique ...